2025-12-31 - Analysis Report
Okay, here's a breakdown of the provided data on Schrodinger Inc. (SDGR), incorporating simple numbers and analysis, with a focus on clarity.

**0) Report Instructions Followed**

The report will be delivered in English, presenting simple numbers first, followed by simple analysis.

**1) Return Rate Comparison with S&P 500 (VOO)**

*   **Ticker:** SDGR
*   **Company Overview:** Schrodinger Inc. is a company that develops software for drug discovery and materials science.
*   **SDGR Cumulative Return:** -55.61%
*   **VOO (S&P 500) Cumulative Return:** 70.37%
*   **Divergence:**
    *   Max: 42.2
    *   Min: -127.1
    *   Current: -125.7
    *   Relative Divergence: 0.8

**Analysis:**

SDGR has significantly underperformed the S&P 500 (VOO) over the period examined. The current divergence is near the minimum observed in the data.  The relative divergence of 0.8 suggests that the current divergence is close to the least divergent it has been. This *could* indicate potential for future convergence, but it's essential to analyze *why* the divergence exists.

**Alpha, Beta Analysis:**

| Year       | CAGR  | MDD  | Alpha  | Beta | Cap(B) |
|------------|-------|------|--------|------|-------|
| 2020-2022  | -70.0% | 78.2% | -76.0% | 0.0  | 1.4   |
| 2021-2023  | -57.0% | 81.0% | -59.0% | -0.0  | 2.6   |
| 2022-2024  | 6.0%  | 81.0% | -14.0% | -0.0  | 1.4   |
| 2023-2025  | -4.0% | 82.6% | -71.0% | -0.0  | 1.3   |

**Analysis:**

*   **CAGR:** Consistently negative CAGR in most periods indicates negative returns over these periods.
*   **MDD:** High Maximum Drawdown (MDD) values signify significant potential losses from peak to trough.
*   **Alpha:** Negative Alpha consistently indicates underperformance relative to a benchmark (likely the S&P 500, although not explicitly stated).
*   **Beta:** Beta near 0 indicates that the stock's price is not as volatile as the market.
*   **Cap(B):** The market capitalization shows the size of the company.

**2) Recent Stock Price Fluctuations**

*   **Current Close:** $17.80
*   **Last Market Data:**
    *   Price: $17.80
    *   Previous Close: $17.84
    *   Change: -$0.22
*   **5-day SMA:** 18.228
*   **20-day SMA:** 17.945
*   **60-day SMA:** 18.8442

**Analysis:**

The current price is slightly below the 5-day and 20-day Simple Moving Averages (SMA), and significantly below the 60-day SMA.  This suggests a recent downward trend.

**3) RSI, PPO, MRI, and Expected Return**

*   **Market Risk Indicator (MRI):** 0.9 (High Investment Recommended)
*   **RSI:** 50.28 (Neutral)
*   **PPO:** 0.3192
*   **Hybrid Signal:** cash_0%_Buy 100% of cash (58 shares - Very Safe - MRI:0.90) Monthly invest 1.4% of total investment ($1,000.00) (Cash Ratio: 0% on 2025-12-01)
*   **Recent Relative Divergence Change:** -0.8 (Short-term decline)
*   **Expected Return (%):** -6562.1% (negative outlook)

**Analysis:**

*   **MRI:** While the MRI is high, suggesting investment, *this contradicts much of the other data.*  The MRI model should be analyzed for robustness, and *not* relied upon solely.
*   **RSI:** An RSI near 50 indicates a neutral position, with no clear overbought or oversold signal.
*   **PPO:** Indicates that the short-term moving average is slightly above the long-term moving average.
*   **Hybrid Signal:** Signal recommends investing all cash.
*   **Divergence Change:** Indicates a recent short-term decline in price relative to the comparison.
*   **Expected Return:** The extremely negative expected return is highly concerning and requires careful consideration.

**4) Recent News & Significant Events:**

*   **[2025-11-10]** "Buy the Bottom" stock (Yahoo Finance, Nasdaq)
*   **[2025-08-21]** Complex Story With Many Moving Parts (Seeking Alpha)
*   **[2025-10-20]** Stock up 14% today (Quiver Quantitative)
*   **[2025-10-30]** Milestone Achievement (Stock Titan)
*   **[2025-12-15]** Shares Gap Up After Analyst Upgrade (MarketBeat)

**Analysis:**

The news is mixed. Some articles suggest a buying opportunity, citing a "bottom" or analyst upgrades. Others highlight the complexity and various factors influencing the company. The news mentioning a significant intraday increase is a short-term observation.

**4-2) Analyst Opinions:**

*   **Consensus:** No Key Provided
*   **Mean:** - (Indicates no consensus or data available)
*   **Opinions:** 9
*   **Target Price (avg/high/low):** 27.22 / 33.00 / 18.00
*   **Recent Rating Changes:**  (Empty, no recent changes provided)

**Analysis:**

Analysts offer a target price range significantly higher than the current price, suggesting potential upside *if* their assessments are accurate. However, the lack of a mean consensus is a concern, meaning this data is unreliable.

**5) Recent Earnings Analysis**

| Date       | EPS   | Revenue   |
|------------|-------|-----------|
| 2025-11-05 | -0.45 | 0.05 B$   |
| 2025-08-06 | -0.59 | 0.05 B$   |
| 2025-05-07 | -0.82 | 0.06 B$   |
| 2024-11-12 | -0.52 | 0.04 B$   |
| 2025-11-05 | -0.52 | 0.04 B$   |

**Analysis:**

The company is consistently losing money (negative EPS) and revenue growth appears stagnant.

**6) Financial Information**

**Revenue and Profitability:**

| Quarter    | Revenue | Profit Margin |
|------------|---------|---------------|
| 2025-09-30 | $0.05B  | 51.61%        |
| 2025-06-30 | $0.05B  | 47.77%        |
| 2025-03-31 | $0.06B  | 52.26%        |
| 2024-12-31 | $0.09B  | 72.61%        |
| 2024-09-30 | $0.04B  | 50.24%        |

**Capital and Profitability:**

| Quarter    | Equity | ROE      |
|------------|--------|----------|
| 2025-09-30 | $0.32B | -10.21%  |
| 2025-06-30 | $0.34B | -12.59%  |
| 2025-03-31 | $0.37B | -16.01%  |
| 2024-12-31 | $0.42B | -9.54%   |
| 2024-09-30 | $0.45B | -8.49%   |

**Analysis:**

*   **Revenue:** Revenue has fluctuated, with a noticeable peak in Q4 2024.
*   **Profit Margin:** Profit margins are relatively high, but this does not translate to overall profitability due to the low revenue numbers.
*   **Equity:** Equity is decreasing over the examined period.
*   **ROE:**  Return on Equity (ROE) is consistently negative, further confirming the lack of profitability.

**7) Comprehensive Analysis**

Based on the data provided, Schrodinger Inc. (SDGR) presents a high-risk investment.

*   **Underperformance:** The stock has significantly underperformed the S&P 500.
*   **Financials:** The company is consistently losing money, has negative returns on equity and shows decreasing equity.
*   **Technical Indicators:** Technical indicators offer a mixed picture, with the MRI suggesting "High Investment Recommended," which contradicts the other evidence.
*   **Analyst Opinions:** Analyst price targets suggest potential upside, but the absence of consensus reduces the reliability of that data.
*   **News:** News is mixed, with some articles promoting a buying opportunity, but the overall picture remains complex.

**Conclusion:**

While there might be some positive news or analyst sentiment, the underlying financial performance and negative expected returns warrant extreme caution. Further due diligence is required.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.